- Drug Class
- Anti-Tuberculous Agent (Rifamycin)
- Mechanism of Action (MOA)
- Inhibits bacterial DNA-dependent RNA polymerase.
- Clinical Notes
- TB (always combination) and meningococcal prophylaxis. Potent CYP450 inducer (↓ OCPs/warfarin); harmless orange-red discoloration of secretions.
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
All pharmacology